MK-0616 is smashing all competitors for the prevention and treatment of atherosclerosis.
Sanofi
Posted inInfections, New Drugs, Regulatory
Beyfortus: Effective Protection for Infants Against Respiratory Syncytial Virus
One injection of nirsevimab reliably protects newborns against the development of RSV-associated lower respiratory tract infections.
Posted inAutoimmune Diseases, Clinical Trials, Metabolism
Insulin Icodec: Basal Insulin Once a Week
Novo Nordisk will offer a very patient-friendly weekly version of insulin.
Posted inClinical Trials, In the Pipeline, Metabolism
Most Effective Weight Loss Drugs: Present and Future
Modern pharmacological ways to combat obesity.
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience
Ublyxi: Highly Effective Drug for Multiple Sclerosis
Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.
Posted inMetabolism, New Drugs, Regulatory
Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory
Enjaymo: First Drug to Treat Cold Agglutinin Disease
Sutimlimab will reduce the need for red blood cell transfusion due to hemolysis.
